Michael Griffin
Stock Analyst at Citigroup
(2.92)
# 1,588
Out of 4,918 analysts
15
Total ratings
100%
Success rate
25.54%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Michael Griffin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| JLL Jones Lang LaSalle | Maintains: Neutral | $275 → $240 | $265.35 | -9.55% | 5 | May 28, 2025 | |
| CBRE CBRE Group | Maintains: Buy | $130 → $160 | $153.94 | +3.94% | 5 | Nov 25, 2024 | |
| AHR American Healthcare REIT | Initiates: Neutral | $14 | $38.89 | -64.00% | 1 | Mar 4, 2024 | |
| HR Healthcare Realty Trust | Maintains: Neutral | $19 → $17 | $16.54 | +2.78% | 2 | Aug 22, 2023 | |
| HPP Hudson Pacific Properties | Maintains: Neutral | $5 → $4.5 | $2.41 | +86.72% | 2 | May 19, 2023 |
Jones Lang LaSalle
May 28, 2025
Maintains: Neutral
Price Target: $275 → $240
Current: $265.35
Upside: -9.55%
CBRE Group
Nov 25, 2024
Maintains: Buy
Price Target: $130 → $160
Current: $153.94
Upside: +3.94%
American Healthcare REIT
Mar 4, 2024
Initiates: Neutral
Price Target: $14
Current: $38.89
Upside: -64.00%
Healthcare Realty Trust
Aug 22, 2023
Maintains: Neutral
Price Target: $19 → $17
Current: $16.54
Upside: +2.78%
Hudson Pacific Properties
May 19, 2023
Maintains: Neutral
Price Target: $5 → $4.5
Current: $2.41
Upside: +86.72%